BNP Paribas Discount Zert MRNA 26.../ DE000PC56VQ3 /
02/08/2024 21:40:14 | Chg.-0.950 | Bid21:59:06 | Ask21:59:06 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
54.070EUR | -1.73% | 54.130 Bid Size: 3,600 |
54.180 Ask Size: 3,600 |
Moderna Inc | - USD | 26/09/2024 | Call |
GlobeNewswire
13/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
05/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
22/05
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
12/05
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
08/05
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/05
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
01/05
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems